These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7862872)

  • 1. Effects of chronic treatment with valproate on serotonin-1A receptor binding and function.
    Khaitan L; Calabrese JR; Stockmeier CA
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):539-42. PubMed ID: 7862872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ.
    Keck BJ; Lakoski JM
    Neuropharmacology; 2000 Apr; 39(7):1237-46. PubMed ID: 10760365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of repeated electroconvulsive shock on serotonin1A receptor binding and receptor-mediated hypothermia in the rat.
    Stockmeier CA; Wingenfeld P; Gudelsky GA
    Neuropharmacology; 1992 Nov; 31(11):1089-94. PubMed ID: 1475018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.
    Alper RH; Nelson DL
    Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lithium treatment enhances the postsynaptic 5-HT1A receptor-mediated 5-HT behavioral syndrome induced by 8-OH-DPAT in rats via catecholaminergic systems.
    Uchitomi Y; Yamawaki S
    Psychopharmacology (Berl); 1993; 112(1):74-9. PubMed ID: 7871012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM; Vilaró MT; Mengod G; Artigas F
    J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats.
    Lund A; Mjellem N
    Pharmacol Biochem Behav; 1993 Aug; 45(4):777-83. PubMed ID: 8415816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acetylsalicylic acid on serotonin brain receptor subtypes.
    Sandrini M; Vitale G; Dondi M; Pini LA
    Gen Pharmacol; 1995 Jul; 26(4):737-41. PubMed ID: 7635248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT(1A) receptor function.
    Mize AL; Poisner AM; Alper RH
    Neuroendocrinology; 2001 Mar; 73(3):166-74. PubMed ID: 11307035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic serotonin-2 receptor agonist or antagonist administration on serotonin-1A receptor sensitivity.
    Hensler JG; Truett KA
    Neuropsychopharmacology; 1998 Nov; 19(5):354-64. PubMed ID: 9778658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desipramine, administered chronically, influences 5-hydroxytryptamine1A-receptors, as measured by behavioral tests and receptor binding in rats.
    Lund A; Mjellem-Jolly N; Hole K
    Neuropharmacology; 1992 Jan; 31(1):25-32. PubMed ID: 1531864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.
    Hedlund PB; Kelly L; Mazur C; Lovenberg T; Sutcliffe JG; Bonaventure P
    Eur J Pharmacol; 2004 Mar; 487(1-3):125-32. PubMed ID: 15033384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT(1A) receptor subsensitivity in infancy and supersensitivity in adulthood in an animal model of depression.
    Shayit M; Yadid G; Overstreet DH; Weller A
    Brain Res; 2003 Aug; 980(1):100-8. PubMed ID: 12865163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
    Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
    J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen modulates 5-HT(1A) agonist inhibition of lordosis behavior but not binding of [(3)H]-8-OH-DPAT.
    Jackson A; Etgen AM
    Pharmacol Biochem Behav; 2001 Feb; 68(2):221-7. PubMed ID: 11267626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
    Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of subchronic dexamethasone treatment on serotonin-2 and beta-adrenergic receptors in the rat cerebral cortex and hippocampus.
    Kuroda Y; Mikuni M; Nomura N; Takahashi K
    Neurosci Lett; 1993 Jun; 155(2):195-8. PubMed ID: 8397352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged effects of intraventricular galanin on a 5-hydroxytryptamine(1A) receptor mediated function in the rat.
    Razani H; Díaz-Cabiale Z; Misane I; Wang FH; Fuxe K; Ogren SO
    Neurosci Lett; 2001 Feb; 299(1-2):145-9. PubMed ID: 11166958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.